Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amicus Therapeutics Inc (NASDAQ:FOLD)

14.28
Delayed Data
As of Sep 01
 -0.10 / -0.70%
Today’s Change
5.13
Today|||52-Week Range
18.83
+71.63%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues293.0K0.000.000.00
 
 
Depreciation And Amortization375.0K363.0K508.0K353.0K
 
 
 
 
 
 
Operating ExpensesGross Income---363.0K-508.0K-353.0K
 
 
 
 
General Expenses17.3M21.1M22.5M25.5M
 
 
 
 
 
Research And Development12.0M15.6M16.1M17.2M
 
 
 
 
 
Total Operating Expenses17.7M21.5M23.0M25.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-17.4M-21.5M-23.0M-25.9M
 
 
 
 
 
Extraordinary Credit600.0K--0.000.00
 
 
Extraordinary Charge-26.0K-511.0K-1.0M-1.1M
 
 
 
 
 
Interest Expense On Debt377.0K378.0K372.0K338.0K
 
 
 
 
 
Other Expenses0.00-47.0K-29.0K-10.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-17.1M-22.3M-24.3M-27.1M
 
 
 
 
 
Income Taxes0.00-1.1M0.000.00
 
 
Net Income-17.1M-21.2M-24.3M-27.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS78.9M87.0M95.7M100.0M
 
 
 
 
 
Shares To Calculate EPS Diluted78.9M87.0M95.7M100.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.22-$0.24-$0.25-$0.27
 
 
 
 
 
EPS Diluted-$0.22-$0.24-$0.25-$0.27